Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Endokrynologia Polska|November 5, 2010
Does the presence of regional lymph node metastases have any impact on the complete remission rate in patients with distant metastases of papillary thyroid carcinoma (PTC), treated by radioiodine therapy?Tomasz Trybek, Aldona Kowalska
Oncology Letters|July 30, 2020
Telomeres and telomerase in oncogenesisTomasz Trybek, Artur Kowalik, Stanisław Góźdź, et al.
Nuclear Medicine Review. Central & Eastern Europe|August 5, 2014
The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scanTomasz Trybek, Aldona Kowalska, Jacek Lesiak, et al.
Plos One|August 1, 2015
The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid CancerAldona Kowalska, Iwona Pałyga, Danuta Gąsior-Perczak, et al.
Endocrinology|July 16, 2019
Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid CancerTomasz Trybek, Agnieszka Walczyk, Danuta Gąsior-Perczak, et al.
Thyroid : Official Journal of the American Thyroid Association|February 19, 2016
Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution StudyAldona Kowalska, Agnieszka Walczyk, Artur Kowalik, et al.
Cancers|November 10, 2019
Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease CourseDanuta Gąsior-Perczak, Artur Kowalik, Agnieszka Walczyk, et al.
Plos One|April 15, 2016
The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer RecurrenceAldona Kowalska, Agnieszka Walczyk, Iwona Pałyga, et al.
Cancers|February 16, 2020
Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?Kinga Hińcza, Artur Kowalik, Iwona Pałyga, et al.
Cancers|February 3, 2021
Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid CarcinomaDanuta Gąsior-Perczak, Artur Kowalik, Krzysztof Gruszczyński, et al.
Pageof 2